$AMGN and $AGN catalyst rundown

FDA approves Amgen and Allergan's MVASI™ (bevacizumab-awwb) for the treatment of five types of cancer. Approval based on totality of evidence from global development program showing MVASI™ is highly similar to Avastin® (bevacizumab). First ever biosimilar to fight cancer approved by FDA.

Full catalyst rundown available in our daily pharma scoop at SeekingAlpha Marketplace page.